Geode Capital Management LLC Has $6.66 Million Holdings in Regencell Bioscience Holdings Limited $RGC

Geode Capital Management LLC increased its position in shares of Regencell Bioscience Holdings Limited (NASDAQ:RGC) by 5,637.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 391,066 shares of the company’s stock after purchasing an additional 384,250 shares during the period. Geode Capital Management LLC’s holdings in Regencell Bioscience were worth $6,664,000 at the end of the most recent reporting period.

Separately, Greenfield Savings Bank acquired a new stake in Regencell Bioscience during the second quarter worth $187,000. Hedge funds and other institutional investors own 0.13% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Regencell Bioscience in a research note on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

Regencell Bioscience Trading Up 1.5%

Shares of RGC stock opened at $16.24 on Friday. The company has a fifty day moving average of $15.00. Regencell Bioscience Holdings Limited has a one year low of $0.09 and a one year high of $83.60.

Regencell Bioscience Profile

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.